The Study is Designed to Evaluate Single Ascending Doses of AR882 in Healthy Adult Males

NCT04347005 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Cohort 1: AR882
DRUG: Cohort 2: AR882
DRUG: Cohort 3: AR882
DRUG: Cohort 4: AR882
DRUG: Cohort 5: AR882
DRUG: Cohort 6: AR882 Food Effect
DRUG: Cohort 7: AR882 Solid Oral Formulation
DRUG: Cohort 8: AR882 in combination with allopurinol
DRUG: Cohort 9: AR882 in combination with febuxostat

Sponsor

Arthrosi Therapeutics